DRAGARWQ5,301.00

Dr Agarwals Eye Hospital Limited

· Pharma & Health
₹ CrorePeersKMCSHILKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMED
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Returns
Return on Common Equity29.5026.0720.24
Return on Assets9.358.919.15
Return on Capital Employed15.5315.0215.21
Return on Invested Capital27.3421.7622.45
Margins
EBITDA Margin28.5229.8430.86
Operating Margin20.1819.9021.17
Incremental Operating Margin18.7527.97
Pretax Margin19.5017.8019.88
Net Income Margin14.5213.7614.89
FCF Margin28.1123.79
Additional
Effective Tax Rate25.5322.7025.11
Dvd Payout Ratio5.574.30
Sustainable Growth Rate27.8624.9520.24
Incremental Operating Margin %18.7527.97
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.